［1］Youlden DR,Cramb SM,Baade PD.The International Epidemiology of Lung Cancer:geographical distribution and secular trends［J］.J Thorac Oncol,2008,3(8):819-831.
［2］Zhang J,Kuai X,Song M,et al.microRNA32 inhibits the proliferation and invasion of the SGC7901 gastric cancer cell line in vitro［J］.Oncol Lett,2014,7(1):270-274.
［3］Fu Y,Wei X,Tang C,et al.Circulating microRNA101 as a potential biomarker for hepatitis B virusrelated hepatocellular carcinoma［J］.Oncol Lett,2013,6(6):1811-1815.
［4］Zhang X,Li X,Tan Z,et al.MicroRNA373 is upregulated and targets TNFAIP1 in human gastric cancer,contributing to tumorigenesis［J］.Oncol Lett,2013,6(5):1427-1434.
［5］Kitamura K,Seike M,Okano T,et al.MiR-134/487b/655 cluster regulates TGF-beta-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells［J］.Mol Cancer Ther,2014,13(2):444-453.
［6］Zhao C,Xu Y,Zhang Y,et al.Downregulation of miR-145 contributes to lung adenocarcinoma cell growth to form brain metastases［J］.Oncol Rep,2013,30(5):2027-2034.
［7］Rani S,Gately K,Crown J,et al.Driscoll L.Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma［J］.Cancer Biol Ther,2013,14(12):1104-1112.
［8］Lambertz I,Nittner D,Mestdagh P,et al.Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo［J］.Cell Death Differ,2010,17(4):633-641.
［9］潘祥林,王鸿利.诊断学的任务与发展方向［J/CD］.中华诊断学电子杂志,2013.1(1):8-9.
［10］Hamamoto J,Soejima K,Yoda S,et al.Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma［J/CD］.Mol Med Rep,2013,8(2):456-462.
［11］Han HS,Yun J,Lim SN,et al.Downregulation of cell-free miR198 as a diagnostic biomarker for lung adenocarcinomaassociated malignant pleural effusion［J］.Int J Cancer,2013,133(3):645-652.
［12］王刚平,张红,梁云爱,等.β-tubulin-Ⅲ、E-cadherin和α-catenin在乳腺癌及癌前病变中的表达及诊断意义［J/CD］.中华诊断学电子杂志,2013,1(1):48-51.
［13］Lin S,Sun JG,Wu JB,et al.Aberrant microRNAs expression in CD133(+)/CD326(+) human lung adenocarcinoma initiating cells from A549［J］.Mol Cells,2012,33(3):277-283.
［14］Avasarala S,Van Scoyk M,Wang J,et al.Hsa-miR29b,a critical downstream target of non-canonical Wnt signaling,plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression［J］.Biol Open,2013,2(7):675-685.
［15］ Kasinski AL,Slack FJ.miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma［J］.Cancer Res，2012，72(21):5576-5587.
［16］ Chiou GY,Cherng JY,Hsu HS,et al.Cationic polyurethanes-short branch PEImediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stemlike properties and in lung adenocarcinoma［J］.J Control Release,2012,159(2):240-250.
［17］ Zhao C,Xu Y,Zhang Y,et al.Downregulation of miR-145 contributes to lung adenocarcinoma cell growth to form brain metastases［J］.Oncol Rep,2013,30(5):2027-2034.
［18］ Cao M,Seike M,Soeno C,et al.MiR-23a regulates TGF-beta-induced epithelial-mesenchymal transition by targeting Ecadherin in lung cancer cells［J］.Int J Oncol,2012,41(3):869-875.
［19］ Lai JH,She TF,Juang YM,et al.Comparative proteomic profiling of human lung adenocarcinoma cells (CL 1-0) expressing miR-372［J］.Electrophoresis,2012,33(4):675-688.
［20］ Meng W,Ye Z,Cui R,et al.MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma［J］.Clin Cancer Res，2013，19(19):5423-5433.
［21］王姣琦，杜珍武，高娴非，等.Bcl-2基因沉默对A549细胞化疗药物杀伤敏感性的影响［J］.中华结核和呼吸杂志，2013：36（3）：191-197.
［22］Cui SY,Huang JY,Chen YT,et al.Let-7c governs the acquisition of chemo-or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxelresistant lung adenocarcinoma［J］.Mol Cancer Res,2013,11(7):699-713.
［23］Kitamura K,Seike M,Okano T,et al.MiR-134/487b/655 cluster regulates TGF-beta-induced epithelialmesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells［J］.Mol Cancer Ther,2013，13（2）：444-453.
［24］Rothschild SI,Tschan MP,Federzoni EA,et al.MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma［J］.Oncogene,2012,31(38):4221-4232.
［25］Kaduthanam S,Gade S,Meister M,et al.Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients［J］.Lung Cancer,2013,80(2):223-227.
［26］Lu Y,Govindan R,Wang L,et al.MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer［J］.Carcinogenesis,2012,33(5):1046-1054.
［27］杨志寅.现代医学科学发展中的缺憾和思考［J/CD］.中华诊断学电子杂志,2013,1(1):1-7.
［28］Gennarino VA,D′Angelo G,Dharmalingam G,et al.Identification of microRNA-regulated gene networks by expression analysis of target genes［J］.Genome Res,2012,22(6):1163-1172.
